Ladies who take birth management medication that contain drospirenone, a artificial progesterone, have a significantly higher risk of developing life-threatening blood clots and sudden caridac arrest. In clinical studies drospirenone has been found to extend the chance of hyperkalemia, an abnormally high concentration of potassium in the bloodstream. Hyperkalemia is characterized by irregular heartbeat, nausea, and a slow, weak pulse. In otherwise healthy ladies with no history of heart disease, untreated hyperkalemia can lead to sudden cardiac arrest.
Hyperkalemia also will increase a girl's risk of developing a blood clot, or thrombus. Clots are presumably to make in massive veins in the legs, a condition known as Deep Vein Thrombosis, or DVT. A thrombus, or clot, is dangerous because of its potential to block blood flow in the blood vessel where it forms, starving the tissues of oxygen. The worse outcome is for the clot to break loose and travel through the circulatory system to the lungs or the center, where it can cause life-threatening problems.
A clot that lodges in a main artery of the lungs is named a pulmonary embolism. Signs of a pulmonary embolism embody shortness of breath, rapid breathing, chest pain, and cyanosis (bluish discoloration of the fingers and lips that indicates insufficient oxygen within the blood). A pulmonary embolism will tough to diagnose, and if it is not treated, it can be fatal. Concerning fifteen% of all sudden deaths are caused by pulmonary embolisms. A clot can also lodge during a major artery and block blood flow to the brain. This will end in a stroke.
Since a birth management pill containing drospirenone was brought to promote in 2003, physicians and researchers have documented the dangerous side effects of this drug. The identical year it had been introduced, Dutch physicians reported on five cases of girls developing DVT or pulmonary thrombosis after they started using it. One in all them, seventeen-year old girl in sensible health who had taken the pill for six months, collapsed suddenly and died shortly afterward. Autopsy revealed a large pulmonary embolism.
A study revealed in 2009 within the widely respected British Journal of Medication followed several thousand Danish women age 15-49 who used oral contraceptives, and who had no history of heart or circulatory problems. They were divided into 2 teams, those that used contraceptives that contained drospirenone, and people whose contraceptives didn't have drospirenone. Health outcomes for the 2 teams were compared. Researchers found considerably more occurrences of DVT and pulmonary embolism within the cluster using contraceptives that contained drospirenone.
Despite the accumulating evidence that use of those drugs caused serious health problems, and had been linked to more than fifty deaths, the manufacturer continued to market them aggressively, and to reap huge profits. In 2008 the manufacturer made more than $1.eight billion from sales of its birth management pill with drosperinone.
In October 2009 the corporate acknowledged that it had been facing more than a hundred twenty five lawsuits by ladies who had been made seriously unwell from its drug. Lawyers familiar with the cases anticipate that because the suits become additional widely known, several more women can come forward with their experiences of health problems. If you've got used an oral contraceptive containing drospirenone and have experienced DVT or a pulmonary embolism, you'll wish to consult an experienced pharmaceutical lawyer to determine whether or not you have a claim.
Author Resource:
Leslie Donner has been writing articles online for nearly 2 years now. Not only does this author specialize in Dangerous Blood Clots Dangerous Side Effects of Birth Management
You can also check out his latest website about
Futurama Action Figures Which reviews and lists the best
Futurama Complete Collection